Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Enyo Pharma
Biotech
Enyo Pharma notches a mid-stage trial win in tricky NASH
Enyo Pharma’s liver disease drug reduced liver fat and boosted kidney health during a mid-stage clinical trial.
Annalee Armstrong
Jul 28, 2021 10:18am
Metacrine raises $65M to kick off NASH clinical testing
Jun 6, 2018 9:51am
Enyo raises $47M to bring hep B, NASH drug to phase 2
Jun 4, 2018 10:18am
Charles River’s target identification tech helps Enyo Pharma
Nov 29, 2017 8:01am
